TELUM THERAPEUTICS
Live / Registered — Registered (as of 28 Mar 2023)
What this means for you
Registered since 28 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79326220
- Registration number
- 7008452
- Mark type
- Design + words
- Filed
- 27 Sept 2021
- Published for opposition
- 10 Jan 2023
- Registered
- 28 Mar 2023
- Attorney of record
- John G. Tutunjian
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for scientific purposes; reagents for medical research use; reagents for medical research in the field of infectious diseases and diseases caused by bacteria; diagnostic reagents for scientific or research use; enzymes for scientific purposes; diagnostic kits comprising specimen receptors being biological tissues cultures and reagents for testing for selected bacteria, other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of diseases caused by bacteria; antibacterial pharmaceuticals; antibiotics; pharmaceutical preparations, namely, biopharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations, namely, immunotherapeutic agents for bacterial infections; enzyme preparations for medical purposes; enzymes for medical purposes; enzymes and enzyme preparations for medical purposes for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; assays, biomarkers and reagents for medical purposes for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria
- Class 042 — Scientific and technological services: Biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; research and development of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; research and development of immunotherapeutic agents for bacterial infections; research and development of enzymes, enzyme preparations and synthetic proteins for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; conducting clinical trials for others of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria
Owner
Prosecution history
- 07 Aug 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 18 Jul 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 Jul 2023 — FINAL DISPOSITION PROCESSED
- 28 Jun 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 24 Jan 2023 — NOTIFICATION PROCESSED BY IB
- 10 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jan 2023 — PUBLISHED FOR OPPOSITION
- 04 Jan 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Jan 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 21 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE